Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Anavex Life Sciences Corp. (AVXL)

  • Event
  • May 27, 2022, 20:30 UTC
  • 9
  • 1 comments

(99% Neutral) ANAVEX LIFE SCIENCES CORP. (AVXL) Files Form 8-K

Comment Full text

Scholar Rock Holding Corp (SRRK)

  • Event
  • May 27, 2022, 20:30 UTC
  • 9
  • 1 comments

(99% Neutral) Scholar Rock Holding Corporation (SRRK) Files Form 8-K

Comment Full text

KalVista Pharmaceuticals Inc (KALV)

  • Event
  • May 27, 2022, 20:12 UTC
  • 9
  • 1 comments

(99% Neutral) KALVISTA PHARMACEUTICALS, INC. (KALV) Announces New Board Appointment

Comment Full text

PTC Therapeutics Inc (PTCT)

  • Event
  • May 27, 2022, 20:12 UTC
  • 9
  • 1 comments

(99% Neutral) PTC THERAPEUTICS, INC. (PTCT) Announces Business Combination

Comment Full text

BeiGene Ltd (BGNE)

  • Event
  • May 27, 2022, 12:33 UTC
  • 8
  • 1 comments

(85% Positive) BEIGENE, LTD. (BGNE) Provides Update on access for follicular lymphomaCAMBRIDGE

Comment Full text

I-Mab (IMAB)

  • Event
  • May 27, 2022, 10:02 UTC
  • 8
  • 1 comments

(90% Positive) I-Mab (IMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Event
  • May 26, 2022, 11:13 UTC
  • 9
  • 1 comments

(99% Neutral) AVADEL PHARMACEUTICALS PLC (AVDL) Announces Regulatory Update

Comment Full text

Marinus Pharmaceuticals Inc (MRNS)

  • Event
  • May 26, 2022, 11:02 UTC
  • 9
  • 1 comments

(50% Neutral) Marinus Pharmaceuticals, Inc. (MRNS) Announces Regulatory Update

Comment Full text

Achilles Therapeutics plc (ACHL)

  • Event
  • May 26, 2022, 10:15 UTC
  • 8
  • 1 comments

(99% Neutral) Achilles Therapeutics plc (ACHL) Announces 2022 Annual General Meeting

Comment Full text

Inhibrx (INBX)

  • Event
  • May 25, 2022, 21:23 UTC
  • 9
  • 1 comments

(99% Neutral) INHIBRX, INC. (INBX) Files Form 8-K

Comment Full text
  • Previous
  • 204
  • 205
  • 206
  • 207
  • 208
  • Next

Search

News categories

  • Technical Exchange News(10881)
  • Event(2261)
  • SEC News(189437)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124581)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin